ACR Convergence 2020 Archives - Page 101 of 139

Abstract Number: 0669

Calcium Pyrophosphate Crystal Deposition in Gouty Tophi
Abstract Number: 1400

cAMP Response Element Modulator (CREM)α Promotes PD-1- effector CD4+ T Cells in Psoriasis and Psoriatic Arthritis
Abstract Number: 0483

Can a Clinical Disease Activity Index Based on Patient-Reported Joint Counts (PT-CDAI) Be Used to Inform Target-Based Care in Telemedicine? An Analysis of 2 Early RA Cohort Studies
Abstract Number: 0922

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex
Abstract Number: 1202

Cannabis Use Assessment and Its Impact on Pain in Rheumatic Diseases: A Systematic Review and Meta-analysis
Abstract Number: 1167

Capturing the Range of Disease Involvement in Localized Scleroderma: The Total Morbidity Score
Abstract Number: 0740

Card9 Promotes Th17-mediated Arthritis and Spondylitis via Control of Acute Pathogenic Neutrophil Responses in SKG Mice
Abstract Number: 1328

Cardiac Biomarkers Are Associated with the Development of Cardiovascular Events in Patients with Psoriatic Arthritis and Psoriasis
Abstract Number: 1172

Cardiovascular involvement as a clue for diagnosis of Juvenile Systemic Sclerosis sine scleroderma
Abstract Number: 1179

Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study
Abstract Number: 1993

Cardiovascular Risk in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
Abstract Number: 0927

Care Gap in Patients with Systemic Sclerosis with CXR Findings Suggestive of Fibrosis
Abstract Number: 1331

Carotid Ultrasound Findings in Psoriatic Arthritis: A Case-control Study
Abstract Number: 1108

Cartilage Biomarkers s-Coll2-1 and s-Coll2-1NO2 Are Associated with Knee Osteoarthritis MRI Features and Predict Disease Worsening
Abstract Number: 1318

Catastrophizing in Patients with Axial Spondyloarthritis and Psoriatic Arthritis
Abstract Number: 1968

Cathepsin S Gene Expression Measured in the Peripheral Blood of Osteoarthritic Patients Prior to Surgery as a Biomarker of Post-operative Pain Development
Abstract Number: 1984

Causal Pathways to Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the ReACCh-Out Cohort
Abstract Number: 0662

Cause-Specific Mortality in Patients with Gout in the Veteran’s Health Administration: A Matched Cohort Study
Abstract Number: 1949

CB2 Receptor Distribution and Effects of LenabasumTM in Dermatomyositis In Vitro
Abstract Number: 0098

CCL2 and CCR2 in Adult Onset Still’s Disease
Abstract Number: 0295

CCL3L3–null Status May Predispose to Systemic Lupus Erythematosus and Non-scarring Alopecia
Abstract Number: 0075

CD209+/CD14+ Dendritic Cells Characterization in Rheumatoid versus Psoriasis Arthritis Patients
Abstract Number: 1575

CD6 Is a Target for Cancer Immunotherapy
Abstract Number: 0841

CD6 Modulation Ameliorates Kidney and Skin Disease in a Spontaneous Murine Lupus Model
Abstract Number: 1411

CD8+ T Cell Subsets and Immune Checkpoint Profiles in Ankylosing Spondylitis Implicate Dysregulation of Cytotoxic T Lymphocytes (CTL)
Abstract Number: 1321

Central Sensitization, Disease Perception and Obesity Should Be Taken into Account When Interpreting Disease Activity in Patients with Axial Spondyloarthritis
Abstract Number: 1358

Certolizumab Pegol Efficacy in Patients with Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
Abstract Number: 1621

Cervical Cancer Screening Among Women with Systemic Lupus Erythematosus or Prescribed Tumor Necrosis Alpha-inhibitors Who Receive Outpatient Rheumatology Care
Abstract Number: 1550

Change in Tophus Size Measured with Dual-energy CT and Ultrasound: A 1-year Multicenter Follow-up Study
Abstract Number: 0610

Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak
Abstract Number: 1382

Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib: Sub-Study of the SENSCIS Trial
Abstract Number: 1817

Changes in Macular Capillary Network Measured with Optical Coherence Tomography-angiography in Patients with Systemic Lupus Erythematosus
Abstract Number: 0434

Changes in Mental Health During the COVID-19 Pandemic Among Individuals with Rheumatic Disease
Abstract Number: 0155

Changes in Patient-Reported Outcome (PRO) Scores for Nausea and Fatigue Following Weekly Methotrexate Dose in a Real-World Sample of RA and PsA Patients in the ArthritisPower Registry
Abstract Number: 0652

Changes in Serum Urate, in the First 6-months of Initiation or Change of Urate-Lowering Therapy, Associate with Immediate Health-Related Quality of Life Outcomes in People with Gout
Abstract Number: 0732

Changing Evidence over Time: Updated Meta-analysis Regarding Anti-TNF Efficacy in Childhood Chronic Uveitis
Abstract Number: 0903

Changing Patterns of Use of Biologic/Targeted Synthetic DMARDs in Psoriatic Arthritis: An Analysis of the OPAL Dataset
Abstract Number: 1520

Characterisation of Rheumatoid and Psoriatic Arthritis Synovial Fibroblasts
Abstract Number: 1469

Characteristics of Adult Patients with Rheumatic Diseases During the COVID-19 Pandemic: Data from an International Patient Survey
Abstract Number: 1071

Characteristics of Anti-Transcription Intermediary Factor 1-gamma Autoantibody Positive Dermatomyositis Patients in Singapore
Abstract Number: 0415

Characteristics of Arthritis in Adult IgA Vasculitis
Abstract Number: 0516

Characteristics of Giant Cell Arteritis Flares After Successful Treatment with Tocilizumab: Results from the Long-Term Extension of a Randomized Controlled Phase 3 Trial
Abstract Number: 0306

Characteristics of Patients with Early Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract Number: 0020

Characteristics of Rheumatology Outpatients with Suspected or Confirmed COVID-19 During the Pandemic in New York City
Abstract Number: 0176

Characterization and Molecular Mechanism Underlying NEMO Deleted Exon 5 Autoinflammatory Syndrome (NDAS)
Abstract Number: 1420

Characterization of ANCA-Associated Vasculitis Among African American Patients
Abstract Number: 0523

Characterization of Antiphospholipid Antibody-Associated Nephropathy: An International Survey of Renal Pathology Society Members
Abstract Number: 1531

Characterization of Cytokine/chemokine Profile in Patient-derived M1/ M2 Macrophages to Identify Biomarkers for Genetically-defined Systemic Autoinflammatory Diseases
Abstract Number: 0473

Characterization of DOCK8 as a Novel Gene Associated with Cytokine Storm Syndrome
Abstract Number: 0533

Characterization of Older Male Patients with a Fragility Fracture
Abstract Number: 0044

Characterization of Racial Disparities in Rheumatoid Arthritis Treatment Choice and Location of Care
Abstract Number: 1355

Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
Abstract Number: 0234

Characterization of Serious Infections with Upadacitinib in Patients with Rheumatoid Arthritis
Abstract Number: 1945

Characterization of Visual Manifestations and Identification of Risk Factors for Permanent Vision Loss in Patients with Giant Cell Arteritis
Abstract Number: 0644

Characterizations of Cytokine Storm Associated with COVID19
Abstract Number: 0072

Characterizing Heterogeneity of Synovial Macrophages in Rheumatoid Arthritis Patients
Abstract Number: 1301

Characterizing How SLE Patients Access Health Information Pre and During COVID-19
Abstract Number: 2038

Characterizing Morphea Subsets Using a Multi-center, Prospective, Cross-sectional Analysis
Abstract Number: 1223

Characterizing Rheumatoid Arthritis Patients by Their Biologic DMARD Prescription History
Abstract Number: 0398

Chest CT Ordering Practices at Expert Scleroderma Centers in the United States
Abstract Number: 0695

Chronic Inflammatory Back Pain Occurring Later in Life: A Neglected Concept
Abstract Number: 0182

Chronic Kidney Disease Is Underestimated in Patients with Rheumatoid Arthritis – Real World Data Gathered from a Network of Rheumatologists
Abstract Number: 0083

Chronic Nonbacterial Osteomyelitis Is Associated with HLA-B*27
Abstract Number: 0963

Chronic Obstructive Pulmonary Disease Associated with Prolonged Opiate Use, Increased Short-Term Complications and the Need for Revision Surgery Following Total Knee Arthroplasty
Abstract Number: 0444

Chronological Order of Decrease of Synovitis, Osteitis and Tenosynovitis in Early Arthritis Patients Receiving First DMARD-treatment
Abstract Number: 1558

Cinematic Rendering Enables Depiction of Bone Anabolic Effects in Patients Treated with Baricitinib
Abstract Number: 2004

Circulating Biomolecules as Potential Biomarkers of Early and Establishedresponse to TNFi Therapy in Rheumatoid Arthritis Patients
Abstract Number: 0744

Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations with Disease Characteristics, Body Composition, and Physical Functioning
Abstract Number: 1445

Citrulline Reactive B Cells Are Present in the Lungs of Risk RA and Early Untreated RA
Abstract Number: 0509

Classification of Patients with Relapsing Polychondritis Based on Somatic Mutations in UBA1
Abstract Number: 0085

Classifications of Inflammatory Myopathies: Differentially Expressed Membrane-Bound Complement Regulators Allow Specific Patterns of Membrane Attack Complex Deposition
Abstract Number: 0777

CLEC12A Expression as a Potential Predictor of Disease Activity in Early Rheumatoid Arthritis
Abstract Number: 0596

Clinical Academic Rheumatology: A Boon for Health Systems
Abstract Number: 1397

Clinical and Demographic Features of Morphea Patients with Mucocutaneous Involvement: A Cross Sectional Study from the Morphea of Adults and Children Cohort
Abstract Number: 0828

Clinical and Functional Response to Tofacitinib in Patients with Rheumatoid Arthritis: Probability Plot Analysis of Results from a Phase 3b/4 Methotrexate Withdrawal Study
Abstract Number: 0025

Clinical and Psychological Assessment of Rheumatoid Arthritis Patients with Fibromyalgia: A Real World Study
Abstract Number: 0637

Clinical and Treatment Features of Rheumatoid Arthritis in HIV-Infected Individuals Followed Longitudinally over Time
Abstract Number: 0915

Clinical Bedside Tools to Assess Systemic Sclerosis Vasculopathy: Can Digital Thermal Monitoring and Sublingual Microscopy Identify Patients with Current or past Digital Ulcers?
Abstract Number: 1279

Clinical Characteristics and Impact of the COVID-19 Pandemic in Systemic Lupus Erythematosus Patients in a Spanish Tertiary Hospital
Abstract Number: 1244

Clinical Characteristics and Outcomes in Patients with Primary Sjögren’s Syndrome-Associated Interstitial Lung Disease
Abstract Number: 1389

Clinical Characteristics and Treatment Outcome of a Cohort of Patients with Joint and Fascial Involvement in the Context of Chronic Graft versus Host Disease
Abstract Number: 0414

Clinical Characteristics of an Internet-Based Cohort of Participants with a Self-Reported Diagnosis of Cryoglobulinemic Vasculitis or IgA Vasculitis
Abstract Number: 1901

Clinical Characteristics of Importance to Outcome in Patients with Axial Spondyloarthritis: A Prospective Cohort Study
Abstract Number: 1572

Clinical Characteristics of Methotrexate Associated Lymphoproliferative Disorders and RA Treatment After Lymphoproliferative Onset in 92 Cases
Abstract Number: 1029

Clinical Characteristics of Patients with Axial Spondyloarthritis in China: Results from the ChinaAS Registry
Abstract Number: 0084

Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort
Abstract Number: 0359

Clinical Characteristics of Psoriatic Arthritis Patients with Physician-Identified Spondylitis, According to HLA-B27 Status: An Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract Number: 1040

Clinical Characteristics of Sarcoidosis in Asian Population: A 14-year Single Center Retrospective Cohort Study from Thailand
Abstract Number: 0409

Clinical Characteristics, Brain MRI Findings, and Diagnostic Approach of the Central Nervous System Vasculitis by Affected Vessel Size
Abstract Number: 1386

Clinical Correlates and Relevance of the UCLA GIT 2.0 Instrument for Indication for Esophagogastroduodenoscopy and Endoscopic Esophagitis in Real-life Patients with Systemic Sclerosis
Abstract Number: 1419

Clinical Disease Might Be Divided into Two Phenotypes in ANCA Associated Vasculitis; Results of a Cluster Analysis
Abstract Number: 1158

Clinical Features and Outcomes in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
Abstract Number: 1511

Clinical Features and Select Dysregulated Immune Parameters Distinguish Blood Relatives Who Remain Clinically Stable or Progress to Incomplete Lupus or Classified SLE in the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort
Abstract Number: 1904

Clinical Features of Patients with Active Ankylosing Spondylitis Who Did Not Respond to Adalimumab but Responded to Ixekizumab: A Post-hoc Analysis
Abstract Number: 1421

Clinical Features, Disease Activity and Prognosis of ANCA-Associated Vasculitis in US African Americans
Abstract Number: 1863

Clinical History as Tool for Diagnosis and Classification of Patients with Ankylosing Spondylitis (Axial Spondyloarthritis): Evidence from a 35-Year Follow-up Family Study of a Swiss Cohort
Abstract Number: 0631

Clinical Manifestations and Outcomes in DMARD-Naïve Patients with Chronic Chikungunya Arthritis
Abstract Number: 1379

Clinical Outcomes Among Participants with Diffuse Systemic Sclerosis Contracting COVID-19 During Clinical Studies of Lenabasum: A Case Series
Abstract Number: 1837

Clinical Outcomes in Lupus Nephritis by Renal Response Status: A Retrospective Analysis of the Hopkins Lupus Cohort
Abstract Number: 0218

Clinical Outcomes of Earlier versus Delayed Treatment of Iraqi Patients with Rheumatoid Arthritis with Etanercept
Abstract Number: 0728

Clinical Outcomes of Juvenile Arthritis in Adulthood: A Systematic Review
Abstract Number: 1418

Clinical Presentations and Follow-up Results of Granulomatosis with Polyangiitis: An Analysis of 8 Years Clinical Experience with 220 Patients from a National Referral Center
Abstract Number: 0826

Clinical Responses and Patient Flow over 2 Years of Treatment with Abatacept, Including Dose De-Escalation, in Patients with Early, MTX-Naïve, ACPA+ RA: Results from a Phase IIIb Study
Abstract Number: 0568

Clinical Timelines and Management Delays in Suspected Giant Cell Arteritis
Abstract Number: 1640

Clinically Important Improvement in Osteoarthritis Pain at Week 16 After Subcutaneous Administration of Tanezumab: Pooled Analysis from International Studies
Abstract Number: 1641

Clinically Important Improvements in Patients with Osteoarthritis Treated with Subcutaneous Tanezumab: Results from a 56-Week Randomized NSAID-Controlled Study
Abstract Number: 0180

Clinicopathological Characteristics of Lymphoproliferative Disorders in 232 Patients with Rheumatoid Arthritis in Japan
Abstract Number: 1444

Cluster-randomized Pragmatic Clinical Trial Evaluating the Potential Benefit of a Tight-control and Treat-to-target Strategy in Axial Spondyloarthritis: The Results of the TICOSPA Trial
Abstract Number: 0343

Co-expression of DC-STAMP and CX3CR1: Biomarkers for Tissue Resident Osteoclasts in Psoriatic Arthritis
Abstract Number: 0641

Cohort of Rheumatic Patients Treated with Rituximab and COVID-19: Does Rituximab Treatment Increases the Severity of SARS-COV2 Infection?
Abstract Number: 0013

Colchicine to Weather the Storm in Hospitalized Patients with COVID-19
Abstract Number: 0355

Collagen Turnover Markers Are Associated with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase-3 Clinical Trial
Abstract Number: 1967

Combating Rheumatologist Burnout: Use of Protocol Driven Medication Refill by Pharmacists
Abstract Number: 0968

Combined Inhibition of Autophagy and Glutamine Metabolism Suppresses Cell Growth of RA Synoviocytes and Ameliorates Arthritis in SKG Mice
Abstract Number: 1534

Combined Thermal and Ultrasound Imaging in Rheumatoid Arthritis Is Superior to Either Imaging Alone in Terms of Correlation with the 28-joint Disease Activity Score
Abstract Number: 1327

Comorbidity Burden in Patients with Non-Radiographic Axial Spondyloarthritis at Least as High as in Ankylosing Spondylitis
Abstract Number: 0368

Comparable Impact and Burden of Disease of Psoriatic Arthritis Patients with Limited Joint Involvement vs. Those with More Extensive Joint Involvement: Interim Results from a Prospective, Multicenter, Real-World Study in Patients Treated with Apremilast
Abstract Number: 1756

Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis
Abstract Number: 0827

Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis
Abstract Number: 0809

Comparative Effectiveness of Intravenous Golimumab vs Dose-Escalated Infliximab in a Real World Population of Rheumatoid Arthritis Patients: 52-Week Data from the AWARE Study
Abstract Number: 1898

Comparative Effectiveness of Secukinumab, Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Axial Spondyloarthritis
Abstract Number: 0333

Comparative Effectiveness of Secukinumab, Adalimumab and Other Tumor Necrosis Factor Inhibitors Used with or Without Methotrexate in the Treatment of Psoriatic Arthritis
Abstract Number: 0334

Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis
Abstract Number: 1357

Comparative Efficacy of Janus Kinase Inhibitors and TNF Inhibitors in Ankylosing Spondylitis: A Network Meta-Analysis
Abstract Number: 0324

Comparative Responsiveness of Outcome Measures in Psoriatic Arthritis: Preparation for Pragmatic Trials
Abstract Number: 0731

Comparing S100 Proteins and Cytokine Levels in Tears Based on Uveitis Activity Laterality in Children with JIA-associated Uveitis and Non-JIA-U
Abstract Number: 1162

Comparison of Clinicopathologic and Imaging Features Between Chronic Nonbacterial Osteomyelitis and Its Mimickers: A Multi-national 450 Case-Control Study
Abstract Number: 0884

Comparison of Disease Control Thresholds in Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract Number: 0403

Comparison of Immediate Post-Operative and Long-Term Outcomes in Aortitis and Non-Inflammatory Thoracic Aortic Aneurysms Undergoing Open Surgical Repair
Abstract Number: 1156

Comparison of Immunological Biomarkers and Lung Histology in Patients with Elevated IL18 – Pulmonary Alveolar Proteinosis and Recurrent Macrophage Activation Syndrome (IL-18PAP-MAS) and Other Inflammatory Lung Diseases
Abstract Number: 1730

Comparison of MBDA Score, Patient Global Assessment and Evaluator Global Assessment for Predicting Risk of Radiographic Progression
Abstract Number: 1648

Comparison of Methotrexate and Glucosamine in Primary Knee Osteoarthritis with Inflammation
Abstract Number: 1637

Comparison of Nation-wide Epidemical Study on 2009 and That on 2019 Revealed That Improvement of Disease Severity and Mortality Rate May Come from Progress of Proficient Management in Patients with Relapsing Polychondritis in Japan
Abstract Number: 1868

Comparison of Quality of Life Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort
Abstract Number: 0507

Comparison of Secukinumab versus Adalimumab Efficacy by Sex in Psoriatic Arthritis from a Phase 3b, Double-blinded, Randomized, Active-controlled Study
Abstract Number: 0797

Comparison of the Efficacy and Safety of Janus Kinase Inhibitors and DMARDs in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis
Abstract Number: 2048

Comparison of Two Rituximab Regimens for Induction of Remission in Antineutrophil Cytoplasm Antibody-associated Vasculitis: Systematic Review and Meta-analysis
Abstract Number: 1871

Comparison of Work Productivity Outcomes Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-Up: Data from the Spondyloarthritis Caught Early Cohort
Abstract Number: 1810

Complement Activation in Systemic Lupus Erythematosus Patients with Low Disease Activity Is Not Inhibited by Hydroxychloroquine
Abstract Number: 2044

Complex, Dynamic Attributes of Antigen-specific T Cells in Rheumatoid Arthritis
Abstract Number: 0280

Compliance and Validation of Patient Reported Outcome Information Collected from Lupus Patients Using a Mobile Application
Abstract Number: 0627

Complications of COVID-19 Infection in Patients with Rheumatic Disease: A Case Series
Abstract Number: 1502

Composite of Relevant Endpoints for Sjögren’s Syndrome (CRESS)
Abstract Number: 1828

Comprehensive Efficacy of Anifrolumab Across Organ Domains in Patients with Active SLE: Pooled Data from 2 Phase 3 Trials
Abstract Number: 1144

Concerns and Behaviors of Patients with Common Autoimmune Rheumatic Diseases in the United States Early in the COVID-19 Pandemic
Abstract Number: 0468

Concerns and Health-Related Behaviors During the COVID-19 Pandemic in Patients with or Without Autoimmune Rheumatic Disease in a Large Physician Network
Abstract Number: 0100

Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases
Abstract Number: PP03

Connecting with Rheumatology Professionals and Thought Leaders Inspired the Creation of a New Program Focused on Relapsing Polychondritis (“RP”), a Rare Rheumatic Disease: Participating at ACR Annual Meetings Has Provided Exceptional Opportunities to Learn and Build Relationships
Abstract Number: 1052

Connective Tissue Disease-Related Interstitial Lung Disease in American Indian/Alaska Native People in Alaska
Abstract Number: 1878

Consensus Definitions for MRI Lesions in the Spine of Patients with Axial Spondyloarthritis: First Analysis from the Assessments in SpondyloArthritis International Society Classification Cohort
Abstract Number: 0741

Constitutive Inhibitor Kappa B (IκB) Kinase 2 (IKK2) Activation Induces an Inflammatory State in Fibroblast-Like Synoviocytes
Abstract Number: 1084

Consumer-based Activity Trackers in Evaluation of Physical Function in Myositis Patients
Abstract Number: 2040

Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON
Abstract Number: 0293

Contraction of the Stool Taxa Clostridia Is Associated with the Development of Clinical Disease Among Anti-Ro+ Mothers of Children with Neonatal Lupus
Abstract Number: 0707

Contribution of NOTUM and Glypicans to the Development of Osteoarthritis
Abstract Number: PP05

Coping Through Advocacy – My Story Living with Relapsing Polychondritis
Abstract Number: 1596

Coproduction of Care for Veterans with RA: Improving Elicitation and Documentation of Patient Goals
Abstract Number: 0413

Coronavirus Infection and Vasculitis: Identifying Associations Mining the Biomedical Literature
Abstract Number: 1506

Correction of Sjögren’s Syndrome Fluid Secretion Deficits in Salivary Gland Acinar Cells by Aquaporin-1 Gene Transfer
Abstract Number: 0616

Correlation Between Disease Activity and Perceived Economic Barriers to Care in a Population of African American Women with Systemic Lupus Erythematosus
Abstract Number: 0252

Corticosteroid and Opioid Use Remain High in Systemic Lupus Erythematosus Patients Receiving Biologic Therapy: A Retrospective Claims Database Analysis
Abstract Number: 0583

Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis
Abstract Number: 0163

Cost of Non-Persistence in the Treatment with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors of Inflammatory Arthritis: A Propensity Score Matching Approach
Abstract Number: 0585

Cost-effectiveness of Motivational Counselling and SMS-reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis
Abstract Number: 1960

Cost-effectiveness of Surgical and Non-Surgical Weight Loss Programs for Morbidly Obese Patients with Knee Osteoarthritis
Abstract Number: 0153

Counseling on Safe Driving Strategies in Patients with Osteoarthritis and Rheumatoid Arthritis
Abstract Number: 0015

COVID -19 Lung Inflammation – What Have We Learnt so Far ?
Abstract Number: 0629

COVID-19 Among Patients with Immune-mediated Inflammatory Diseases: A Descriptive Study
Abstract Number: 0640

Covid-19 and Rheumatic and Musculoskeletal Disease Patients: Infection Rates, Attitudes and Medication Adherence
Abstract Number: 1339

COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
Abstract Number: 1274

COVID-19 in Patients with Systemic Lupus Erythematosus
Abstract Number: 1497

COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance
Abstract Number: 0008

COVID-19 Infection Among Patients with Rheumatic Disease on Biologic & Targeted Therapies: A Systematic Review
Abstract Number: 0642

COVID-19 Infection in Rheumatologic Patients on Treatment with Targeted Therapies
Abstract Number: 1280

COVID-19 Infections May Increase the Risk of SLE Flares
Abstract Number: PP12

COVID-19, Racism, and Gender Discrimination: The Function of Stress in Widening the Gap in Health Disparities
Abstract Number: 0051

COVID-Related Distress and Mental Health in Adult Rheumatology Patients During the COVID-19 Pandemic
Abstract Number: 0923

Criteria for the Diagnosis of Raynaud’s Phenomenon – Do They Recognize the Same Patients?
Abstract Number: 1230

Curcumin: Prevalence and Perceived Efficacy in the Treatment of Rheumatoid and Psoriatic Arthritis
Abstract Number: 1859

Curdlan-induced Villous Permeability, Luminal Pathobiont Translocation to the Ileal Crypts, Ileitis and Arthritis Are Mitigated by Clostridia in Colonised Germ-free SKG Mice
Abstract Number: 1700

Curricular Implementation of the Rheumatic Disease Patient Expert Program: The Students’ Perspective
Abstract Number: 1610

Cutaneous Side Effects of Hydroxychloroquine in Rheumatic Diseases –Combination of “Traditional” Multivariate Analysis for Risk Factors AndClassification Model Development Using Supervised Machine Learning –Single Centre Retrospective Cohort Study in India
Abstract Number: 0999

CXCL13 Is a Key Driver for Migration and Differentiation of Regulatory B Cells
Abstract Number: 0285

CXCL13 Neutralization Reduces Neuropsychiatric Manifestations in MRL/lpr Mice
Abstract Number: 0027

CYP2D6 Genotype and Reduced Codeine Analgesic Effect in Real-World Clinical Practice
Abstract Number: 0623

Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort
Abstract Number: 0449

Cytotoxic T Cells with a Chronic Antigen Exposure Phenotype Drive Immune Checkpoint Inhibitor Sicca